Biotech and Healthcare News
GSK has shelved its chronic cough treatment, camlipixant, after mixed Phase 3 data prompted the British pharma to cease development, making it the third from its class to fail.
Digital Health / MedTech / BioTechDigital Health / MedTech / BioTech
FDA Approval Controversy: Delayed Brain Cancer Treatment and Kidney Disease Drug
Northwest Biotherapeutics' brain cancer treatment, DCVax, has been under review for over 931 days after submitting a marketing application to the U.K.'s Medicines and Healthcare products Regulatory Agency in late December 2023.
Digital Health / MedTech / BioTechU.S. Employer-Based Health Insurance System in Crisis
The employer-based health insurance system in the U.S. is crumbling, with a high likelihood that workers get their health insurance from their job or the job of a loved one.
Digital Health / MedTech / BioTechEli Lilly Eliminates 340B Drug Discounts for Non-Compliant Hospitals
Eli Lilly has begun eliminating mandated price breaks to a few dozen hospitals that participate in a federal drug discount program after failing to receive comprehensive claims data.
Digital Health / MedTech / BioTechRegulatory Shifts Rock Healthcare Industry
Following Vijay Kumar's exit, acting CBER Director Karim Mikhail will oversee a review office that has become a battleground for debates on FDA flexibility.
Digital Health / MedTech / BioTechCMS Proposes Expanded Medicare Coverage for TAVR Procedures
The Centers for Medicare and Medicaid Services (CMS) has proposed expanding Medicare coverage for transcatheter aortic valve replacement (TAVR) procedures, which could help Edwards Lifesciences gain market share from Medtronic and Boston Scientific.
Digital Health / MedTech / BioTechRoche to Acquire Digital Pathology Firm PathAI for Cancer Diagnosis and Treatment
Roche plans to acquire digital pathology firm PathAI in a deal potentially worth over $1 billion, with the goal of improving cancer diagnosis and tailored treatment.
Digital Health / MedTech / BioTech